And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 ...

"Ozempic 2.0" has been floating around online, as a trending nickname for the next generation of weight loss drugs that are in the works.

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients. “ Ozempic is about to be ...

The Food and Drug Administration is set to treat the application under its priority program to accelerate the review of ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Novo Nordisk reported promising mid-stage results for its experimental obesity drug amycretin in diabetes patients on Tuesday ...

The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during ...

Grandes Inc. (3261.TO) Japan Nine Months Ended September 30 GROUP 2025 2024 Revenue Y2.32 bln Y2.61 bln Operating Profit (Y38.00 mln) Y5.00 mln Pretax Profit (Y37.00 mln) Y6.00 mln Net Profit (Y61.00 ...

NEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try it. Kiran, a 27-year-old financial trader who has ...

The deal with pharmaceutical companies Eli Lilly and Company and Novo Nordisk is expected to dramatically reduce costs of Ozempic and Wegovy — which the president has affectionately dubbed "The Fat ...

During an announcement about lowering prices for weight-loss medications, Donald Trump referenced his communications director, Steve Cheung, saying he takes Ozempic. The comment came as Trump promoted ...